배합 화학요법 시장 : 약제 유형별, 배합 환경별, 투여 경로별, 환자 유형별, 암 유형별, 유통 채널별, 배합 방법별, 포장 유형별, 규제 대응별, 지역별
Compounding Chemotherapy Market, By Drug Type, By Compounding Setting, By Route of Administration, By Patient Type, By Cancer Type, By Distribution Channel, By Compounding Method, By Packaging Type, By Regulatory Compliance, By Geography
상품코드
:
1741163
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
배합 화학요법 시장은 2025년 58억 2,000만 달러, 2032년에는 81억 3,000만 달러에 이를 것으로 예측되며, 2025-2032년 연간 평균 성장률(CAGR)은 4.9%를 나타낼 전망입니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
58억 2,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
4.90% |
2032년 금액 예측 |
81억 3,000만 달러 |
배합화학요법이란 의약품 성분을 환자 개개인의 필요에 따라 맞춤형 약품으로 만드는 것을 말합니다. 이러한 배경에는 전 세계 암 발병률 증가와 특수 약물 제제에 대한 요구가 있습니다. 암 치료가 더욱 개인화됨에 따라 화합물은 환자에게 특정 질병, 상태 및 민감도에 적합한 제제를 제공하는 데 중요한 역할을 하고 있습니다. 암에 걸리기 쉬운 노인 증가, 정밀의료와 표적치료에 대한 관심 증가, 시판 중인 약물의 부족은 전 세계적으로 복합 화학요법 서비스의 채택을 촉진하는 주요 요인 중 일부입니다.
시장 역학
암, 골수 질환, 면역계 질환과 같은 질병의 유병률 증가는 예측 기간 동안 세계 복합 화학요법 시장의 성장을 가속할 것입니다. 처방약에 대한 비용 증가와 결제 정책의 변화는 예측 기간 동안 세계 복합 화학요법 시장의 성장을 다시 한 번 증가시킬 것으로 예측됩니다. 제품에서 얻을 수 있는 소비자 건강 혜택 증가는 세계 복합 화학요법 시장에 새로운 기회를 창출할 것으로 예측됩니다. 병원 및 헬스케어 산업에서 복합 화학요법 치료 및 의약품에 대한 인식이 높아짐에 따라 시장 확대가 촉진될 것으로 예측됩니다.
세계보건기구(WHO)에 따르면, 암 환자 수는 2000년 이후 거의 두 배로 증가했으며, 향후 20년 동안 70% 이상 증가할 것으로 예측됩니다. 개인 맞춤형 치료 옵션과 가치관에 따른 의료 모델에 대한 인식이 높아지면서 종양내과 개업의들이 조제 서비스를 도입하고 있습니다. 또한, 특히 소아암에 대한 시판 의약품의 부족은 이 시장 진출기업들에게 성장 기회를 제공합니다. 그러나 오염의 위험, 복잡한 제제 제조의 기술적 문제, 국가별로 일관성 없는 규제 환경은 시장 확대에 걸림돌이 될 수 있습니다. 약국 조제에서 3D 프린팅의 적용이 확대됨에 따라 향후 몇 년 동안 약물 전달을 개선하고 개별화된 투약 설계를 가능하게 하는 새로운 길을 열 수 있을 것으로 보입니다.
본 조사의 주요 특징
- 이 보고서는 세계의 복합 화학요법 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR%)을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 복합 화학요법 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 화합물 화학요법 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 복합 화학요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 규제 시나리오
- 제품 발매 및 승인
- PEST 분석
- Porter's Five Forces 분석
- 인수합병(M&A) 시나리오
제4장 배합 화학요법 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제에 대한 영향
제5장 배합 화학요법 시장, 약제 유형별, 2020-2032년
- 서론
- 세포 상해성 약제
- 호르몬제
- 면역조절제
- 표적치료
- 지지요법 약물
제6장 배합 화학요법 시장, 배합 환경별, 2020-2032년
- 서론
- 병원 조제
- 조제 약국
- 전문 클리닉
- 홈케어
제7장 배합 화학요법 시장, 투여 경로별, 2020-2032년
- 서론
- 정맥내(IV)
- 경구
- 피하(SC)
- 근육내(IM)
- 척수내(IT)
제8장 배합 화학요법 시장, 환자 유형별, 2020-2032년
제9장 배합 화학요법 시장, 암 유형별, 2020-2032년
- 서론
- 유방암
- 폐암
- 대장암
- 전립선암
- 백혈병
- 림프종
- 기타 특정 암 유형
제10장 배합 화학요법 시장, 유통 채널별, 2020-2032년
제11장 배합 화학요법 시장, 배합 방법별, 2020-2032년
제12장 배합 화학요법 시장, 포장 유형별, 2020-2032년
제13장 배합 화학요법 시장, 규제 대응별, 2020-2032년
제14장 배합 화학요법 시장, 지역별, 2020-2032년
- 서론
- 북미
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN 국가
- 기타 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제15장 경쟁 구도
- Braun Melsungen AG
- Fagron NV
- PharMEDium Services, LLC(AmerisourceBergen Corporation)
- Baxter International Inc.
- Fresenius Kabi AG
- Advanced Pharma, Inc.
- McGuff Compounding Pharmacy Services, Inc.
- Central Admixture Pharmacy Services, Inc.(CAPS)
- Institutional Pharmacy Solutions, LLC
- Wedgewood Pharmacy
- Medisca Inc.
- Dougherty's Holdings, Inc.
- PharMEDium Services, LLC(AmerisourceBergen Corporation)
- BioScrip, Inc.
제16장 섹션
LSH
영문 목차
Compounding Chemotherapy Market is estimated to be valued at USD 5.82 Bn in 2025 and is expected to reach USD 8.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.9% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 5.82 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
4.90% |
2032 Value Projection: |
USD 8.13 Bn |
Compounding chemotherapies refer to the customization of pharmaceutical ingredients into medication tailored to individual patient needs. This has been largely driven by the rise in cancer prevalence worldwide and the need for specialized drug formulations. As cancer treatments become more personalized, compounding plays a crucial role in providing patients with formulations suited to their specific disease, condition, or sensitivity. Growing geriatric population prone to developing cancers, increasing emphasis on precision medicine and targeted therapies, and shortages of commercially available drugs are some of the key factors fueling the adoption of compounding chemotherapy services globally.
Market Dynamics:
The increasing prevalence of illnesses like cancer, bone marrow conditions, and immune system problems will continue to fuel the growth of the global compounding chemotherapy market over the forecast period. Increasing costs for prescription drugs and changing payment policies are again expected to augment global compounding chemotherapy market growth over the forecast period. Rising consumer health benefits from the products will create new opportunities for the global compounding chemotherapy market. Hospitals and the healthcare industry are becoming more aware of compounded chemotherapy treatments or medicines, which is also assisting in the market's expansion.
According to the World Health Organization, the cancer burden has nearly doubled since 2000 and is expected to grow by over 70% in the next two decades. Increased awareness about personalized treatment options and value-based healthcare models is encouraging oncology practitioners to adopt compounding services. The shortage of commercially manufactured drugs, especially for pediatric cancer, also presents growth opportunities for players in this market. However, risks of contamination, technical challenges in preparing complex formulations, and an inconsistent regulatory environment across countries could hinder the market expansion to some extent. The growing application of 3D printing in pharmacy compounding is likely to open up new avenues, allowing for improved drug delivery and personalized dosage designs in the coming years.
Key features of the study:
- This report provides in-depth analysis of the global compounding chemotherapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global compounding chemotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include B. Braun Melsungen AG, Fagron NV, PharMEDium Services, LLC (AmerisourceBergen Corporation), Baxter International Inc., Fresenius Kabi AG, Advanced Pharma, Inc., McGuff Compounding Pharmacy Services, Inc., Central Admixture Pharmacy Services, Inc. (CAPS), Institutional Pharmacy Solutions, LLC, Wedgewood Pharmacy, Medisca Inc., Dougherty's Holdings, Inc., PharMEDium Services, LLC (AmerisourceBergen Corporation), BioScrip, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global compounding chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding chemotherapy market
Global Compounding Chemotherapy Market Detailed Segmentation:
- By Drug Type:
- Cytotoxic Drugs
- Hormonal Agents
- Immunomodulatory Agents
- Targeted Therapies
- Supportive Care Drugs
- By Compounding Setting:
- Hospital Compounding
- Compounding Pharmacies
- Specialty Clinics
- Homecare Settings
- By Route of Administration:
- Intravenous (IV)
- Oral
- Subcutaneous (SC)
- Intramuscular (IM)
- Intrathecal (IT)
- By Patient Type:
- Adult Patients
- Pediatric Patients
- Geriatric Patients
- By Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Leukemia
- Lymphoma
- Other specific cancer types
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Compounding Method:
- Aseptic Compounding
- Non-aseptic Compounding
- By Packaging Type:
- Vials
- Ampoules
- Pre-filled Syringes
- Bottles
- By Regulatory Compliance:
- USP Chapter <797> Compliance
- FDA Regulations
- EMA Regulations
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profile:
- B.Braun Melsungen AG
- Fagron NV
- PharMEDium Services, LLC (AmerisourceBergen Corporation)
- Baxter International Inc.
- Fresenius Kabi AG
- Advanced Pharma, Inc.
- McGuff Compounding Pharmacy Services, Inc.
- Central Admixture Pharmacy Services, Inc. (CAPS)
- Institutional Pharmacy Solutions, LLC
- Wedgewood Pharmacy
- Medisca Inc.
- Dougherty's Holdings, Inc.
- BioScrip, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Compounding Chemotherapy, By Drug Type
- Market Compounding Chemotherapy, By Compounding Setting
- Market Compounding Chemotherapy, By Route of Administration
- Market Compounding Chemotherapy, By Patient Type
- Market Compounding Chemotherapy, By Cancer Type
- Market Compounding Chemotherapy, By Distribution Channel
- Market Compounding Chemotherapy, By Compounding Method
- Market Compounding Chemotherapy, By Packaging Type
- Market Compounding Chemotherapy, By Regulatory Compliance
- Market Compounding Chemotherapy, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing demand for Personalized Medicine
- Increasing prevalence of illnesses like cancer
- The High cost of compounding chemotherapeutic products
- Rising consumer health benefits from the products
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Compounding Chemotherapy Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Compounding Chemotherapy Market, By Drug Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cytotoxic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Hormonal Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Immunomodulatory Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Targeted Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Supportive Care Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Compounding Chemotherapy Market, By Compounding Setting, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Hospital Compounding
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Compounding Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Compounding Chemotherapy Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Intrathecal (IT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Compounding Chemotherapy Market, By Patient Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Compounding Chemotherapy Market, By Cancer Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Other specific cancer types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
10. Compounding Chemotherapy Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
11. Compounding Chemotherapy Market, By Compounding Method, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Aseptic Compounding
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Non-aseptic Compounding
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
12. Compounding Chemotherapy Market, By Packaging Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Bottles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
13. Compounding Chemotherapy Market, By Regulatory Compliance, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- USP Chapter <797> Compliance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- FDA Regulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- EMA Regulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
14. Compounding Chemotherapy Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- South Africa
- Central Africa
- North Africa
15. Competitive Landscape
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fagron NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PharMEDium Services, LLC (AmerisourceBergen Corporation)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Advanced Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- McGuff Compounding Pharmacy Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Central Admixture Pharmacy Services, Inc. (CAPS)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Institutional Pharmacy Solutions, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Wedgewood Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Medisca Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dougherty's Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PharMEDium Services, LLC (AmerisourceBergen Corporation)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioScrip, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
16. Section
- Research Methodology
- About us
관련자료
